To gain more insight into the contribution of CD36 rare coding mutations to T2D and its cardio-metabolic complications, we screened 184 unrelated French individuals of European ancestry presenting simultaneously with T2D, arterial hypertension, dyslipidemia and history of coronary heart disease. This evidence concerns the gene CD36 and type 2 diabetes mellitus.